Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absent, ABSSI, Agriculture, Alex, AMR, analyst, Anef, assembled, attorney, Avycaz, Baby, bioresearch, Biotech, Blank, blister, Bloomberg, Britain, CCPA, CDE, cefazolin, Ceiling, cephalexin, Chesapeake, Christine, Christopher, cleaning, Click, clinicial, codified, Colorado, combat, Compamy, compelled, compulsory, constitutionality, content, conversion, Cope, CPRA, Cubicin, cut, Dainippon, Dalton, DC, deadline, Deputy, dicloxacilin, dicloxacillin, driver, dubbed, EGM, England, environment, evidentiary, expert, FCA, Florida, foster, founder, Fox, FSS, GISP, gouging, grated, Hampshire, harbor, Hatch, HBr, HMR, hypoxemia, ID, immigration, incentivizing, inevitable, infiltrate, inpart, instability, Instruction, Josh, Koch, Krystal, lactate, Lincoln, Lisa, lobar, lowest, LPC, Manila, MBA, McKesson, MD, Mexico, monotherapeutic, Moraxella, MPH, multinational, nafcillin, Naftzger, NDC, Noah, novation, Nuzyra, Oncology, oxacillin, pallidu, PCT, petitioner, PHI, Philadelphia, PLI, postponed, preexisting, prioritization, prioritized, provisional, provisionally, RCC, relaunch, Resiliency, resurgence, Roadmap, Rockledge, Rome, RTF, Santo, scalable, Scheinfeld, Scotland, shock, SI, SIP, Spain, standing, sulopenem, Sumitomo, Suzhou, talented, tap, text, tie, tier, timeline, Treponema, Tricare, undergraduate, Unilife, unnecessary, unrealizable, unrest, vabomere, variant, Vermont, vi, Waxman, Welfare, Willamette, word, workforce, worn, XENLENTA, Zemdri
Removed:
ads, Ambulatory, angioedema, ASU, Bad, beta, biology, Boston, Calixa, Cantor, Cempra, Cerexa, CFO, characterize, Circuit, close, conform, Consortium, constitute, Continental, CT, Dendreon, disruptive, Durata, earliest, electorate, expedient, FDASIA, fellowship, Fitzgerald, FNIH, Forest, founding, frame, Francesco, Fulbright, hereditary, ImClone, interpret, kg, King, landlord, Lavino, leave, leaving, Maria, marketer, McMaster, momentum, Morgan, Norton, OfferingSM, outlining, PPACA, practical, predominantly, Princeton, Prussia, psychology, Reauthorization, rest, retroactively, rolled, Rose, rulemaking, serving, stopped, summer, Survey, Tengion, tenure, Toronto, underwriting, underwritten, Wesleyan, Yale, Zuperbug
Filing tables
Filing exhibits
Related press release
Associated NBRVF transcripts
NBRVF similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-208097, 333-222003, 333-226330, 333-228094, 333-230216, 333-240178, 333-254157 and 333-260927) on Form S-8, (Nos. 333-219567, 333-223739 and 333-248530) on Form S-3 and (No. 333-260146) on Form S-1 of our report dated March 29, 2022, with respect to the consolidated financial statements of Nabriva Therapeutics plc.
/s/ KPMG LLP
Philadelphia, Pennsylvania
March 29, 2022